Status:
ACTIVE_NOT_RECRUITING
Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety
Lead Sponsor:
University Hospital, Caen
Conditions:
Cancer
Side Effect of Drug
Eligibility:
All Genders
Brief Summary
Little is known about cancer therapy-related radiopharmaceuticals drugs safety. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of indivi...
Detailed Description
Radiopharmaceuticals drugs especially for therapeutic purposes are responsible of a wide range of side effects. The investigators use VigiBase, the World Health Organization (WHO) database of individu...
Eligibility Criteria
Inclusion
- cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase)
Exclusion
- not related to radiopharmaceuticals
Key Trial Info
Start Date :
May 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
500000 Patients enrolled
Trial Details
Trial ID
NCT06483685
Start Date
May 30 2024
End Date
August 1 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen Normandy University Hospital
Caen, Normandy, France, 14033